Neuraxis, INC
NRXSNYSECIK 1933567HealthcareFiscal year ends Dec 31
Reports and events: 62 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1421:00 ET | 8-K | 8.01 Other events | 0001493152-26-047034 |
| 2026-08-1921:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001493152-26-039247 |
| 2026-08-1111:00 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-036978 |
| 2026-07-1011:00 ET | 8-K | 8.01 Other events | 0001493152-26-032769 |
| 2026-06-1220:50 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-028489 |
| 2026-05-1211:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-022384 |
| 2026-04-2821:00 ET | DEF 14A | Proxy statementPeriod 2026-06-10 | 0001140361-26-017498 |
| 2026-04-2220:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-018580 |
| 2026-04-2121:28 ET | 8-K | 2.02 Results of operations | 0001493152-26-018376 |
| 2026-03-1911:00 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-011505 |
| 2025-11-1022:01 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-021547 |
| 2025-10-2412:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-019186 |
| 2025-10-2321:27 ET | 8-K | 2.02 Results of operations | 0001493152-25-019136 |
| 2025-09-0213:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-026158 |
| 2025-08-1210:51 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-023100 |
| 2025-07-0317:20 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-017723 |
| 2025-06-0420:30 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-013632 |
| 2025-05-2820:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-012698 |
| 2025-05-2210:45 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-011973 |
| 2025-05-2121:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-011939 |
| 2025-05-1212:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-009571 |
| 2025-04-1413:00 ET | DEF 14A | Proxy statementPeriod 2025-05-29 | 0001140361-25-013641 |
| 2025-03-2012:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001493152-25-010984 |
| 2025-01-0814:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-001323 |
| 2024-12-0216:53 ET | SC 13D | Ownership report, active investor | 0001622627-24-000064 |
| 2024-11-2521:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-24-047623 |
| 2024-11-2122:17 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-24-047196 |
| 2024-11-1521:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-046285 |
| 2024-11-1213:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-044545 |
| 2024-11-1213:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-044538 |
| 2024-10-1821:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-041597 |
| 2024-09-1320:33 ET | 8-K | 3.02 Unregistered sale of equity | 0001493152-24-036212 |
| 2024-08-2120:15 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-033444 |
| 2024-08-0912:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-030875 |
| 2024-08-0912:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-030873 |
| 2024-07-0520:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-026362 |
| 2024-07-0120:05 ET | DEF 14A | Proxy statementPeriod 2024-08-15 | 0001140361-24-031946 |
| 2024-05-2820:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-24-021615 |
| 2024-05-2020:18 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-020692 |
| 2024-04-1620:33 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-014832 |
| 2024-04-1620:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-24-014829 |
| 2024-04-0920:27 ET | 8-K | 2.02 Results of operations; 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001493152-24-014075 |
| 2024-03-2820:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-011761 |
| 2024-03-1112:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-009493 |
| 2024-02-1522:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-24-006888 |
| 2024-01-3114:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-004424 |
| 2023-12-1922:00 ET | 8-K | 8.01 Other events | 0001493152-23-045436 |
| 2023-11-2022:15 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-042163 |
| 2023-11-1414:58 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-040826 |
| 2023-09-2220:16 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-033460 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.